Purdue Pharma received approval for the company's disclosure statement tied to its chapter 11 reorganization plan that aims to deliver more than $7.4 billion in cash to creditors to compensate victims ...

All 50 states as well as the District of Columbia and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma, maker of Oxycontin, over the company's improper marketing of opioids.